A Real World Experience of Combined Treatment with Romidepsin and Azacitidine in Patients with Peripheral T-Cell Lymphoma

被引：2
|
作者：
Kalac, Matko [1 ]
Tam, Constantine Si Lun [2 ]
Goldfinger, Mendel [3 ]
Xiao, Zhengrui [4 ]
Montanari, Francesca [5 ]
Kanakry, Jennifer A. [6 ]
O'Connor, Owen [7 ]
Marchi, Enrica [8 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[3] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Oncol, Div Hematol Malignancies, Bronx, NY 10467 USA
[4] Montefiore Med Ctr, New York, NY USA
[5] Yale Sch Med, Greenwich, CT USA
[6] NCI, Expt Transplantat & Immunol Branch, Bethesda, MD 20892 USA
[7] Univ Virginia, Div Hematol Oncol, Program T Cell Lymphoma Res, Charlottesville, VA USA
[8] Univ Virginia, Program T Cell Lymphoma Res, Charlottesville, VA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-144651
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4550
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma
    Bates, Susan E.
    Zhan, Zhirong
    Steadman, Kenneth
    Obrzut, Tomasz
    Luchenko, Victoria
    Frye, Robin
    Robey, Robert W.
    Turner, Maria
    Gardner, Erin R.
    Figg, William D.
    Steinberg, Seth M.
    Ling, Alex
    Fojo, Tito
    To, Kin Wah
    Piekarz, Richard L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (02) : 256 - 267
  • [42] A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma
    Holkova, Beata
    Yazbeck, Victor
    Kmieciak, Maciej
    Bose, Prithviraj
    Ma, Shuo
    Kimball, Amy
    Tombes, Mary Beth
    Shrader, Ellen
    Wan, Wen
    Weir-Wiggins, Caryn
    Singh, Amanda
    Hogan, Kevin T.
    Conine, Sarah
    Sankala, Heidi
    Roberts, John D.
    Shea, Thomas C.
    Grant, Steven
    LEUKEMIA & LYMPHOMA, 2017, 58 (06) : 1349 - 1357
  • [43] The Novel Nano-Formulation of the HDAC Inhibitor, Romidepsin, for the Treatment of Relapsed, Refractory Peripheral T-Cell Lymphoma
    Pal, Ipsita
    Illendula, Anuradha
    Manavalan, John Sanil
    Fox, Todd P.
    O'Connor, Owen A.
    Loughran, Thomas P. Jr Jr
    Kester, Mark
    Feith, David J.
    Marchi, Enrica
    BLOOD, 2022, 140 : 8848 - 8849
  • [44] Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses
    Coiffier, Bertrand
    Pro, Barbara
    Prince, H. Miles
    Foss, Francine
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Morschhauser, Franck
    Wilhelm, Martin
    Pinter-Brown, Lauren
    Iyer, Swaminathan Padmanabhan
    Shustov, Andrei
    Nielsen, Tina
    Nichols, Jean
    Wolfson, Julie
    Balser, Barbara
    Horwitz, Steven
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7
  • [45] Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study
    Shimony, Shai
    Horowitz, Netanel
    Ribakovsky, Elena
    Rozovski, Uri
    Avigdor, Abraham
    Zloto, Keren
    Berger, Tamar
    Avivi, Irit
    Perry, Chava
    Abadi, Uri
    Raanani, Pia
    Gafter-Gvili, Anat
    Gurion, Ronit
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (05) : 569 - 577
  • [46] Current Treatment of Peripheral T-cell Lymphoma
    Stuver, Robert
    Epstein-Peterson, Zachary D.
    Johnson, William T.
    Khan, Niloufer
    Lewis, Natasha
    Moskowitz, Alison J.
    Sauter, Craig S.
    Horwitz, Steven M.
    ONCOLOGY-NEW YORK, 2022, 36 (05): : 293 - 305
  • [47] Chidamide in the treatment of peripheral T-cell lymphoma
    Chan, Thomas S.
    Tse, Eric
    Kwong, Yok-Lam
    ONCOTARGETS AND THERAPY, 2017, 10 : 347 - 352
  • [48] Romidepsin in Japanese patients with relapsed or refractory peripheral T-cell lymphoma: a phase I/II and pharmacokinetics study
    Maruyama, Dai
    Tobinai, Kensei
    Ogura, Michinori
    Uchida, Toshiki
    Hatake, Kiyohiko
    Taniwaki, Masafumi
    Ando, Kiyoshi
    Tsukasaki, Kunihiro
    Ishida, Takashi
    Kobayashi, Naoki
    Ishizawa, Kenichi
    Tatsumi, Yoichi
    Kato, Koji
    Kiguchi, Toru
    Ikezoe, Takayuki
    Laille, Eric
    Ro, Tokihiro
    Tamakoshi, Hiromi
    Sakurai, Sanae
    Ohtsu, Tomoko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (05) : 655 - 665
  • [49] Controversies in the Treatment of Peripheral T-cell Lymphoma
    Bachy, Emmanuel
    Broccoli, Alessandro
    Dearden, Claire
    de Leval, Laurence
    Gaulard, Philippe
    Koch, Raphael
    Morschhauser, Franck
    Truemper, Lorenz
    Zinzani, Pier Luigi
    HEMASPHERE, 2020, 4 (05): : E461
  • [50] Peripheral T-cell lymphoma: diagnosis and treatment
    Reimer, P
    Hentrich, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (13) : 685 - 690
12345